Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EUCRATES BIOMEDICAL ACQUISITION CORP.

(EUCR)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021

07/16/2021 | 04:07pm EST

Eucrates Biomedical Acquisition Corp. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced operating loss was USD 125,348. Net income was USD 1.994 million.


ę S&P Capital IQ 2021
All news about EUCRATES BIOMEDICAL ACQUISITION CORP.
2021EUCRATES BIOMEDICAL ACQUISITION CORP. - 10-K/A - Management's Discussion and Analysis o..
AQ
2021EUCRATES BIOMEDICAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIA..
AQ
2021Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Third Quarter an..
CI
2021EUCRATES BIOMEDICAL ACQUISITION CORP : Non-Reliance on Previous Financials, Audits or Inte..
AQ
2021EUCRATES BIOMEDICAL ACQUISITION : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
2021EUCRATES BIOMEDICAL ACQUISITION : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
2021Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the First Quarter En..
CI
2021EUCRATES BIOMEDICAL ACQUISITION : 10-K/A - Management's Discussion and Analysis of Financi..
AQ
2021EUCRATES BIOMEDICAL ACQUISITION CORP : Non-Reliance on Previous Financials, Audits or Inte..
AQ
2021EUCRATES BIOMEDICAL ACQUISITION : Receives Non-Compliance Notice from Nasdaq
MT
More news
Financials (USD)
Sales 2020 - - -
Net income 2020 -14,8 M - -
Net cash 2020 0,55 M - -
P/E ratio 2020 -
Yield 2020 -
Capitalization 131 M 131 M -
EV / Sales 2019
EV / Sales 2020 -
Nbr of Employees -
Free-Float -
Chart EUCRATES BIOMEDICAL ACQUISITION CORP.
Duration : Period :
Eucrates Biomedical Acquisition Corp. Technical Analysis Chart | EUCR | VGG3141W1068 | MarketScreener
Income Statement Evolution
Managers and Directors
Parag Phoolchand Saxena Chief Executive Officer & Director
Evangelos Vergetis President, Chief Operating Officer & Director
Gonzalo Cordova Chief Financial Officer
Stelios Papadopoulos Chairman
Daphne Karydas Independent Director
Sector and Competitors